Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Goodman. Insider Profile
4 Followers
David Goodman., Director at Neurometrix, holds 0.00 shares in Xtant Medical Holdings (Ticker: XTNT), holds 834.00 shares in Neurometrix (Ticker: NURO), holds 0.00 shares in Masimo (Ticker: MASI).
David Goodman. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Goodman. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Goodman.
David Goodman.'s Trading History
Neurometrix
May 22, 2013
Director
Uninformative Buy
159.60
$1.70K
Xtant Medical Holdings
Jul 06, 2016
Director
Uninformative Buy
―
$0.00
Masimo
―
EVP BD
―
$0.00
List of latest transactions for each holding click on a transaction to see David Goodman.'s performance on stock
You May Also Like
David Goodman. insider profile FAQ
What is the percentage of profitable transactions made by David Goodman.?
The percentage of profitable transactions made by David Goodman. is ―.
What is the average return per transaction made by David Goodman.?
The average return per transaction made by David Goodman. is ―.
What stocks does David Goodman. hold?
David Goodman. holds: NURO, XTNT, MASI stocks.
What was David Goodman.’s latest transaction?
David Goodman. latest transaction was an Uninformative Buy of ―.
What was David Goodman.'s most profitable transaction?
David Goodman.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Goodman.'s role in Neurometrix?
David Goodman.'s role in Neurometrix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.